• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症患者的髂嵴骨量与重塑

Iliac crest bone mass and remodelling in acromegaly.

作者信息

Halse J, Melsen F, Mosekilde L

出版信息

Acta Endocrinol (Copenh). 1981 May;97(1):18-22. doi: 10.1530/acta.0.0970018.

DOI:10.1530/acta.0.0970018
PMID:7223314
Abstract

Iliac crest bone biopsies from 18 patients with active acromegaly, of whom 11 had received tetracycline double-labelling, were evaluated by quantitative histomorphometry and compared with age- and sex-matched normal controls. A significant increase (P less than 0.01) was found in both cortical (175%) and trabecular (130%) bone mass. In trabecular bone, resorption surfaces and active (tetracycline-labelled) and total formation surfaces were increased (P less than 0.05 and P less than 0.01, respectively) causing an enhanced bone turn-over at tissue level (P less than 0.01). The increased trabecular bone mass indicates a positive net balance per remodelling cycle and, therefore, larger than normal bone remodelling units, which in part may explain the increased bone turn-over at tissue level. The activity of the osteoblasts active in mineralization (the appositional rate) was increased (P less than 0.01) and positively related to the fasting serum growth hormone levels (Rs = 0.69, P less than 0.05). The average activity of active and inactive osteoblasts (bone formation rate at basic metabolic unit (BMU) level) was insignificantly increased. The proportion of active (tetracycline labelled) to nonactive formation surfaces was normal. The bone changes were unrelated to serum levels and urinary excretions of calcium and phosphorus or to renal excretion of total and non-dialyzable hydroxyproline or cAMP.

摘要

对18例活动性肢端肥大症患者的髂嵴骨活检标本进行了评估,其中11例接受了四环素双标记,采用定量组织形态计量学方法,并与年龄和性别匹配的正常对照进行比较。发现皮质骨(175%)和小梁骨(130%)骨量均显著增加(P<0.01)。在小梁骨中,吸收表面、活跃(四环素标记)和总形成表面均增加(分别为P<0.05和P<0.01),导致组织水平的骨转换增强(P<0.01)。小梁骨量增加表明每个重塑周期的净平衡为正,因此,骨重塑单位大于正常,这在一定程度上可以解释组织水平骨转换增加的原因。参与矿化的成骨细胞活性(沉积速率)增加(P<0.01),且与空腹血清生长激素水平呈正相关(Rs=0.69,P<0.05)。活跃和不活跃成骨细胞的平均活性(基本代谢单位(BMU)水平的骨形成速率)略有增加。活跃(四环素标记)与非活跃形成表面的比例正常。骨变化与血清钙、磷水平及尿排泄量,或与总羟脯氨酸和非透析性羟脯氨酸或环磷酸腺苷的肾排泄量无关。

相似文献

1
Iliac crest bone mass and remodelling in acromegaly.肢端肥大症患者的髂嵴骨量与重塑
Acta Endocrinol (Copenh). 1981 May;97(1):18-22. doi: 10.1530/acta.0.0970018.
2
A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism.基于四环素的甲状腺功能亢进症和甲状旁腺功能亢进症骨吸收和骨转换的组织形态计量学评估
Acta Med Scand. 1978;204(1-2):97-102. doi: 10.1111/j.0954-6820.1978.tb08406.x.
3
A histomorphometric determination of iliac bone remodeling in patients with recurrent renal stone formation and idiopathic hypercalciuria.复发性肾结石形成和特发性高钙尿症患者髂骨重塑的组织形态计量学测定
APMIS. 1989 Apr;97(4):309-16. doi: 10.1111/j.1699-0463.1989.tb00793.x.
4
Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism.甲状腺功能亢进症中的骨骼变化:骨形态计量学、甲状腺功能与钙磷代谢之间的相互关系
Acta Endocrinol (Copenh). 1977 Jul;85(3):515-25. doi: 10.1530/acta.0.0850515.
5
Bone histomorphometry in acromegaly patients with fragility vertebral fractures.肢端肥大症患者脆性椎体骨折的骨组织形态计量学。
Pituitary. 2018 Feb;21(1):56-64. doi: 10.1007/s11102-017-0847-1.
6
Histomorphometric analysis of iliac trabecular bone in otosclerosis.
Acta Otolaryngol. 1984 Mar-Apr;97(3-4):305-8. doi: 10.3109/00016488409130993.
7
Structural and histomorphometric studies of iliac crest trabecular and cortical bone in autosomal dominant osteopetrosis: a study of two radiological types.
Bone. 1989;10(1):19-24. doi: 10.1016/8756-3282(89)90142-7.
8
Morphometric and dynamic studies of bone changes in hypothyroidism.甲状腺功能减退症骨骼变化的形态计量学与动态研究
Acta Pathol Microbiol Scand A. 1978 Jan;86(1):56-62. doi: 10.1111/j.1699-0463.1978.tb02012.x.
9
The nature of the metabolic bone disorder in acromegaly.肢端肥大症中代谢性骨病的本质。
J Clin Endocrinol Metab. 1972 Jun;34(6):911-8. doi: 10.1210/jcem-34-6-911.
10
Effect of antithyroid treatment on calcium-phosphorus metabolism in hyperthyroidism. II: Bone histomorphometry.抗甲状腺治疗对甲状腺功能亢进症钙磷代谢的影响。II:骨组织形态计量学。
Acta Endocrinol (Copenh). 1978 Apr;87(4):751-8. doi: 10.1530/acta.0.0870751.

引用本文的文献

1
Neuroendocrinology of bone.骨的神经内分泌学
Pituitary. 2024 Dec;27(6):761-777. doi: 10.1007/s11102-024-01437-5. Epub 2024 Aug 3.
2
Persistent Deficits in Bone Quality in Treated Acromegaly: Evidence From Assessments of Microstructure.经治疗的肢端肥大症患者骨质量持续存在缺陷:来自微观结构评估的证据。
J Endocr Soc. 2023 Sep 20;7(10):bvad121. doi: 10.1210/jendso/bvad121. eCollection 2023 Aug 28.
3
Endocortical Trabecularization in Acromegaly: The Cause for the Paradoxically Increased Vertebral Fracture Risk?肢端肥大症中的骨内膜小梁化:椎体骨折风险反常增加的原因?
JBMR Plus. 2023 Aug 11;7(10):e10787. doi: 10.1002/jbm4.10787. eCollection 2023 Oct.
4
Differences between bone health parameters in adults with acromegaly and growth hormone deficiency: A systematic review.肢端肥大症和生长激素缺乏症成人骨健康参数的差异:系统评价。
Best Pract Res Clin Endocrinol Metab. 2023 Dec;37(6):101824. doi: 10.1016/j.beem.2023.101824. Epub 2023 Sep 28.
5
Musculoskeletal Effects of Altered GH Action.生长激素作用改变对肌肉骨骼系统的影响。
Front Physiol. 2022 May 19;13:867921. doi: 10.3389/fphys.2022.867921. eCollection 2022.
6
Hip Structure Analyses in Acromegaly: Decrease of Cortical Bone Thickness After Treatment: A Longitudinal Cohort Study.肢端肥大症患者的髋部结构分析:治疗后皮质骨厚度降低:一项纵向队列研究。
JBMR Plus. 2019 Oct 23;3(12):e10240. doi: 10.1002/jbm4.10240. eCollection 2019 Dec.
7
Bone histomorphometry in acromegaly patients with fragility vertebral fractures.肢端肥大症患者脆性椎体骨折的骨组织形态计量学。
Pituitary. 2018 Feb;21(1):56-64. doi: 10.1007/s11102-017-0847-1.
8
Acromegalic osteopathy.肢端肥大性骨病
Pituitary. 2017 Feb;20(1):63-69. doi: 10.1007/s11102-016-0758-6.
9
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis.生长激素/胰岛素样生长因子-1 对骨代谢和骨质疏松症的影响。
Int J Endocrinol. 2014;2014:235060. doi: 10.1155/2014/235060. Epub 2014 Jul 23.
10
Growth hormone, insulin-like growth factors, and the skeleton.生长激素、胰岛素样生长因子与骨骼
Endocr Rev. 2008 Aug;29(5):535-59. doi: 10.1210/er.2007-0036. Epub 2008 Apr 24.